LMR Partners »

Bridgebio Pharma shares owned by LMR Partners

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by LMR Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2M 105k 40.37
2023-06-30 $20M 1.1M 17.20

More positions owned by LMR Partners

Ishares Tr Russell 2000 Etf Call Option (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Ishares Tr National Mun Etf Call Option (MUB)
Pdd Holdings Note10/0 (Principal)
On Semiconductor Corp Note5/0 (Principal)
Tripadvisor Put Option (TRIP)
Cytokinetics Note 4.000%11/1 (Principal)
Rivian Automotive Com Cl A Put Option (RIVN)
Advanced Micro Devices Call Option (AMD)
Dish Network Corporation Note 3.375% 8/1 (Principal)
BP Sponsored Adr (BP)
NVIDIA Corporation (NVDA)
United States Steel Corporation (X)
Carnival Corp Common Stock Put Option (CCL)

View all positions for LMR Partners

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
Aisling Capital Management
Laurion Capital Management
Cormorant Asset Management
Goldman Sachs Group
Lord, Abbett & Co
Frazier Life Sciences Management
Alliancebernstein
Perceptive Advisors
Citigroup
Wellington Management Company
Hillhouse Capital Advisors
Norges Bank Investment Management

View all funds holding Bridgebio Pharma